Search Results - Robert P. Castleberry
- Showing 1 - 20 results of 23
- Go to Next Page
-
1
Clinical Significance of <i>MYCN</i> Amplification and Ploidy in Favorable-Stage Neuroblastoma: A Report From the Children's Oncology Group by Jennifer Schneiderman, Wendy B. London, Garrett M. Brodeur, Robert P. Castleberry, A. Thomas Look, Susan L. Cohn
Published 2008Artigo -
2
Outcomes of the POG 9340/9341/9342 trials for children with high‐risk neuroblastoma: A report from the Children's Oncology Group by Peter E. Zage, Morris Kletzel, Kevin Murray, Robert Marcus, Robert P. Castleberry, Yang Zhang, Wendy B. London, Cynthia S. Kretschmar
Published 2008Artigo -
3
Preradiation chemotherapy with methotrexate, cisplatin, 5‐fluorouracil, and leucovorin for pediatric nasopharyngeal carcinoma by Carlos Rodríguez‐Galindo, Marcia M. Wofford, Robert P. Castleberry, Gregory P. Swanson, Wendy B. London, James Fontanesi, Alberto S. Pappo, Edwin C. Douglass
Published 2005Artigo -
4
Recommendations for modification of terminology of neuroblastic tumors and prognostic significance of Shimada classification. A clinicopathologic study of 213 cases from the pediat... by Vijay Joshi, Alan Cantor, Geoffrey Altshuler, Ernest W. Larkin, James S. Neill, Jonathan J. Shuster, C. Tate Holbrook, F. Ann Hayes, Robert P. Castleberry
Published 1992Artigo -
5
Phase II Randomized Comparison of Topotecan Plus Cyclophosphamide Versus Topotecan Alone in Children With Recurrent or Refractory Neuroblastoma: A Children's Oncology Group Study by Wendy B. London, Christopher Frantz, Laura Campbell, Robert C. Seeger, Babette Brumback, Susan L. Cohn, Katherine K. Matthay, Robert P. Castleberry, Lisa Diller
Published 2010Artigo -
6
Hyperdiploidy Plus Nonamplified <i>MYCN</i> Confers a Favorable Prognosis in Children 12 to 18 Months Old With Disseminated Neuroblastoma: A Pediatric Oncology Group Study by Rani E. George, Wendy B. London, Susan L. Cohn, John M. Maris, Cynthia S. Kretschmar, Lisa Diller, Garrett M. Brodeur, Robert P. Castleberry, A. Thomas Look
Published 2005Artigo -
7
A Pilot Study of Isotretinoin in the Treatment of Juvenile Chronic Myelogenous Leukemia by Robert P. Castleberry, Peter D. Emanuel, Kenneth S. Zuckerman, Susan L. Cohn, Lewis C. Strauss, Rebecca L. Byrd, Alan Homans, Sarah Chaffee, Ruprecht Nitschke, Richard J. Gualtieri
Published 1994Artigo -
8
Detection of MYCN Gene Amplification in Neuroblastoma by Fluorescence In Situ Hybridization: A Pediatric Oncology Group Study by Prasad Mathew, Marcus B. Valentine, Laura C. Bowman, Susan Rowe, Michael B. Nash, Virginia Valentine, Susan L. Cohn, Robert P. Castleberry, Garrett M. Brodeur, A. Thomas Look
Published 2001Artigo -
9
Prognostic Factors in Children With Extragonadal Malignant Germ Cell Tumors: A Pediatric Intergroup Study by Neyssa Marina, Wendy B. London, A. Lindsay Frazier, Stephen J. Lauer, Frederick J. Rescorla, Barbara Cushing, Marcio H. Malogolowkin, Robert P. Castleberry, Richard B. Womer, Thomas A. Olson
Published 2006Artigo -
10
The International Neuroblastoma Pathology Classification (the Shimada system) by Hiroyuki Shimada, Inge M. Ambros, Louis P. Dehner, Junichi Hata, Vijay Joshi, Borghild Roald, Daniel O. Stram, Robert B. Gerbing, John N. Lukens, Katherine K. Matthay, Robert P. Castleberry
Published 1999Artigo -
11
Psychological Outcomes in Long-Term Survivors of Childhood Brain Cancer: A Report From the Childhood Cancer Survivor Study by Brad Zebrack, James G. Gurney, Kevin C. Oeffinger, John Whitton, Roger J. Packer, Ann C. Mertens, Norman Turk, Robert P. Castleberry, ZoAnn E. Dreyer, Leslie L. Robison, Lonnie K. Zeltzer
Published 2004Artigo -
12
Outcomes of Children With Intermediate-Risk Neuroblastoma After Treatment Stratified by <i>MYCN</i> Status and Tumor Cell Ploidy by Rochelle Bagatell, Pavlina Rumcheva, Wendy B. London, Susan L. Cohn, A. Thomas Look, Garrett M. Brodeur, Christopher Frantz, Vijay Joshi, Paul S. Thorner, Pejaver V. Rao, Robert P. Castleberry, Laura C. Bowman
Published 2005Artigo -
13
Ocular late effects in childhood and adolescent cancer survivors: A report from the childhood cancer survivor study by Kimberly Whelan, Kayla Stratton, Toana Kawashima, John W. Waterbor, Robert P. Castleberry, Marilyn Stovall, Charles A. Sklar, Roger J. Packer, Pauline Mitby, Candice L. Aitken, Julie Blatt, Leslie L. Robison, Ann C. Mertens
Published 2009Artigo -
14
Intensified Platinum Therapy Is an Ineffective Strategy for Improving Outcome in Pediatric Patients With Advanced Hepatoblastoma by Marcio H. Malogolowkin, Howard M. Katzenstein, Mark Krailo, Zhengjia Chen, Laura C. Bowman, Marleta Reynolds, Milton J. Finegold, Brian Greffe, Jon Rowland, Kurt D. Newman, Richard B. Womer, Wendy B. London, Robert P. Castleberry
Published 2006Artigo -
15
Minority Adult Survivors of Childhood Cancer: A Comparison of Long-Term Outcomes, Health Care Utilization, and Health-Related Behaviors From the Childhood Cancer Survivor Study by Sharon M. Castellino, Jacqueline Casillas, Melissa M. Hudson, Ann C. Mertens, John Whitton, Sandra Brooks, Lonnie K. Zeltzer, Arthur R. Ablin, Robert P. Castleberry, Wendy L. Hobbie, Sue C. Kaste, Leslie L. Robison, Kevin C. Oeffinger
Published 2005Artigo -
16
Residential Pesticide Exposure and Neuroblastoma by Julie L. Daniels, Andrew F. Olshan, Kay Teschke, Irva Hertz‐Picciotto, David A. Savitz, Julie Blatt, Melissa L. Bondy, Joseph P. Neglia, Brad H. Pollock, Susan L. Cohn, A. Thomas Look, Robert C. Seeger, Robert P. Castleberry
Published 2001Artigo -
17
The mutational spectrum of PTPN11 in juvenile myelomonocytic leukemia and Noonan syndrome/myeloproliferative disease by Christian P. Kratz, Charlotte M. Niemeyer, Robert P. Castleberry, Mualla Çetin, Eva Bergsträßer, Peter D. Emanuel, Henrik Hasle, G Kardos, Cornelia Klein, Seiji Kojima, Jan Starý, Monika Trebo, Marco Zecca, Bruce D. Gelb, Marco Tartaglia, Mignon L. Loh
Published 2005Artigo -
18
Outcome after Reduced Chemotherapy for Intermediate-Risk Neuroblastoma by David L. Baker, Mary Lou Schmidt, Susan L. Cohn, John M. Maris, Wendy B. London, Allen Buxton, Daniel O. Stram, Robert P. Castleberry, Hiroyuki Shimada, Anthony D. Sandler, Robert C. Shamberger, A. Thomas Look, C. Patrick Reynolds, Robert C. Seeger, Katherine K. Matthay
Published 2010Artigo -
19
Neuroblastoma: Effect of genetic factors on prognosis and treatment by Garrett M. Brodeur, C G Azar, Michele B. Brother, Jill L. Hiemstra, Bruce A. Kaufman, Helen Marshall, Jeffrey F. Moley, Akira Nakagawara, Robert L. Saylors, N J Scavarda, Sandra Schneider, Jonathon Wasson, Peter S. White, Robert C. Seeger, Thomas Look, Robert P. Castleberry
Published 1992Artigo -
20
Fibrolamellar hepatocellular carcinoma in children and adolescents by Howard M. Katzenstein, Mark Krailo, Marcio H. Malogolowkin, Jorge A. Ortega, Wenchun Qu, Edwin C. Douglass, James H. Feusner, Marleta Reynolds, John J. Quinn, Kurt D. Newman, Milton J. Finegold, Joel E. Haas, Martha G. Sensel, Robert P. Castleberry, Laura C. Bowman
Published 2003Revisão
Search Tools:
Related Subjects
Medicine
Internal medicine
Biology
Oncology
Genetics
Cell culture
Neuroblastoma
Chemotherapy
Cancer
Surgery
Gastroenterology
Paleontology
Stage (stratigraphy)
Cyclophosphamide
Gene
Pathology
Regimen
Stem cell
Cancer research
Cisplatin
Environmental health
Haematopoiesis
Juvenile myelomonocytic leukemia
Leukemia
Pediatric oncology
Pediatrics
Bone marrow
Chromosome
Cohort
Confidence interval